Skip to main navigation Skip to search Skip to main content

Empyema in a Patient with Schizophrenia Using Clozapine: A Case Report

Research output: Contribution to journalArticlepeer-review

Abstract

Schizophrenia is associated with a high risk of thoracic infections and pneumonia. The use of atypical antipsychotics clozapine may also increase the risk of pulmonary infection. However, psychotic patients are less likely to report physical symptoms, and these dangerous conditions may go undetected. In this case report, we present 47-year-old woman with schizophrenia who had been using clozapine and did not complain of respiratory symptoms. After admission, she was diagnosed with streptococcus intermedius empyema. Although empyema has a high mortality rate, thanks to the timely admission and proper diagnosis, the patient recovered after 3 weeks of medical and surgical treatment.

Original languageEnglish
Pages (from-to)184-187
Number of pages4
JournalPsychiatry and Clinical Psychopharmacology
Volume32
Issue number2
DOIs
Publication statusPublished - Jun 2022

Bibliographical note

Publisher Copyright:
© 2022, AVES. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Schizophrenia
  • Streptococcus intermedius
  • clozapine
  • empyema
  • infection

Fingerprint

Dive into the research topics of 'Empyema in a Patient with Schizophrenia Using Clozapine: A Case Report'. Together they form a unique fingerprint.

Cite this